By Thomas Anderson, Rotem Petranker — 2018
We just ran the first ever pre-registered scientific study on the microdosing of psychedelics and found some very promising results.
Read on theconversation.com
CLEAR ALL
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
1
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.